Component

Young-mouse physical-function response to fisetin

Context-specific entity; species, compartment and exposure are stated on each claim.

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

  1. Fisetin did not improve the measured physical-function outcomes in young mice in the age-comparison study.

    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Same intermittent-supplementation study.
    limitations
    No detectable improvement in these endpoints is not proof of no biological activity.
    nutrient_topic
    Fisetin collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Fisetin
    plain_language
    Benefit was not universal across age groups.
    primary_references
    Intermittent Supplementation With Fisetin Improves Physical Function and Decreases Cellular Senescence in Skeletal Muscle With Aging: A Comparison to Genetic Clearance of Senescent Cells and Synthetic Senolytic Approaches. · 2025 · https://pubmed.ncbi.nlm.nih.gov/40437670/ · DOI 10.1111/acel.70114

    Fisetin: metabolism, cell-state responses and cross-nutrient mechanisms (2026-09-19) · lines 240–246

    AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Same intermittent-supplementation study. · source_derived_draft · unverified_draft

    ## fisetin-young-mouse-null Benefit was not universal across age groups. Fisetin did not improve the measured physical-function outcomes in young mice in the age-comparison study. Model: Same intermittent-supplementation study. Limitations: No detectable improvement in these endpoints is not proof of no biological activity. Evidence access: Primary abstract Intermittent Supplementation With Fisetin Improves Physical Function and Decreases Cellular Senescence in Skeletal Muscle With Aging: A Comparison to Genetic Clearance of Senescent Cells and Synthetic Senolytic Approaches. · 2025 · https://pubmed.ncbi.nlm.nih.gov/40437670/ · DOI 10.1111/acel.70114
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards